What changed today in Aesthetics & Longevity: 1 trial update

Why this matters

New clearances, safety communications and research in aesthetic and regenerative medicine affect what practices offer, how they describe it and what patients are told.

What changed

1. New trial registered: Efficacy and Safety of Triple-Combination Cream Plus Microneedling Along With Tranexamic Acid Versus Platelet-Rich Plasma in the Treatment of…[1]
2. Also reported by Dermatology Times: “Navigating New Treatments From Alopecia to Atopic Dermatitis”.[2]

Who this affects

• Med spas
• Medical directors
• Prescribers
• Practice owners & operators
• Pharmacies

What to watch next

No new verified deadlines in today’s records. See Deadline Watch for upcoming dates.

Source file

1. [1]
   New trial registered: Efficacy and Safety of Triple-Combination Cream Plus Microneedling Along With Tranexamic Acid Versus Platelet-Rich Plasma in the Treatment of… (opens the source in a new tab)

   Primary sourceClinicalTrials.gov (U.S. National Library of Medicine)Oct 22, 2026

2. [2]
   Navigating New Treatments From Alopecia to Atopic Dermatitis (opens the source in a new tab)

   News reportingDermatology TimesOct 23, 2026Industry coverage — headline and link only

Compiled automatically from primary official sources and peer-reviewed literature. Each line is a factual summary of a public record, linked to it — no interpretation is added. NPHLA links to sources and does not republish their text. Professional information only — not medical, legal or regulatory advice for any individual situation. Our standards.